Can a probiotic gel help women clear HPV and early cervical lesions?

NCT ID NCT06582004

Ongoing Disease control Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a natural vaginal gel called CH2 can help women with mild cervical changes (CIN1) and high-risk HPV clear the infection and heal faster. Fifty women will use either the gel or a placebo twice a week for 24 weeks. Researchers will track Pap smear results and HPV tests every 3 months to see if the gel improves regression rates.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CH2 vaginal gel (a dietary supplement made from water, probiotic glycerol, and plant extracts)
What this could lead to: If it works, this could offer a natural option to help the body clear early cervical changes and HPV faster, reducing the need for more invasive procedures.
What could go wrong: This is a small, early-stage trial with only 50 participants, so results may not apply to everyone. The gel is a supplement, not a proven treatment, and many CIN1 cases resolve on their own anyway.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL INTRAEPITHELIAL NEOPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical intraepithelial neoplasia dysplasia of cervix human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL INTRAEPITHELIAL NEOPLASIA HUMAN PAPILLOMAVIRUS

Contacts and locations

Locations

National Taiwan University Hospital

Taipei City, Taipei, 110, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.